Recently, Reuters released a special report entitled “Big Pharma’s global guinea pigs” . Its main premise is that today’s clinical trials business has gone global mainly because drugmakers seek “cheaper venues for studies and… ‘treatment-naive’ patients”. But drug makers and
→